CO 042: IMPACT OF AN ANTIBIOTIC POLICY ON ANTIMICROBIAL CONSUMPTION AT COMANDANTE MANUEL FAJARDO UNIVERSITY HOSPITAL, 2011

Excerpt:


J Pharm Pharmacogn Res 2(Suppl. 1): S23, 2014 Special supplement with the abstract book of LATINFARMA 2013 Oral Communication CO 042: IMPACT OF AN ANTIBIOTIC POLICY ON ANTIMICROBIAL CONSUMPTION AT COMANDANTE MANUEL FAJARDO UNIVERSITY HOSPITAL, 2011 Morejón M, Tirado J, Jiménez A, Mulen M. Hospital Universitario “Cmdte. Manuel Fajardo”, Zapata y D, Vedado, La Habana, … Continue reading CO 042: IMPACT OF AN ANTIBIOTIC POLICY ON ANTIMICROBIAL CONSUMPTION AT COMANDANTE MANUEL FAJARDO UNIVERSITY HOSPITAL, 2011

J Pharm Pharmacogn Res 2(Suppl. 1): S23, 2014

Special supplement with the abstract book of LATINFARMA 2013

Oral Communication

CO 042: IMPACT OF AN ANTIBIOTIC POLICY ON ANTIMICROBIAL CONSUMPTION AT COMANDANTE MANUEL FAJARDO UNIVERSITY HOSPITAL, 2011

Morejón M, Tirado J, Jiménez A, Mulen M.

Hospital Universitario “Cmdte. Manuel Fajardo”, Zapata y D, Vedado, La Habana, Cuba. E-mail: moisesm@infomed.sld.cu
Abstract

Introduction: At present, it is unanimous among scientists that the use of antibiotics, specifically their misuse, is the most significant factor in the emergence and development of bacterial resistance. Today, over 50% of hospitalized patients receive antibiotics; it is considered that 25-50% is unnecessary. This has concerned all levels. That is why; the WHO issued a document in 2001: “Strategies to contain antimicrobial resistance,” which states in its first page that the main cause of bacterial resistance is the inappropriate use of antimicrobials. Therefore, one of its recommendations calls for the creation of antibiotic policies and monitoring their consumption in all health institutions.

Objectives: To determine how the patterns of antimicrobial prescriptions vary with the application of an antibiotic policy.

Results: There was a variation of consumption in the cephalosporin family, which was further used; cefuroxime was the highest consumed, three times more than ceftriaxone, whereas cefazolin was only used in surgical prophylaxis, and cefepime was only used in the intensive care units. meropenem and piperazicillina/tazolbactam were only used on serious case in the care units.

Conclusions: The patterns of prescription of antimicrobial drugs met favorably the recommended guidelines for the policy of antibiotics use, which could promote a more rational use of them.

Toxicity evaluation of Ruta angustifolia leaves ethanolic extract
J. Pharm. Pharmacogn. Res., vol. 11, no. 3, pp. 437-447, May-June 2023. DOI: https://doi.org/10.56499/jppres23.1609_11.3.437 Original Article Acute and repeated dose 28-day oral toxicity of Ruta angustifolia Pers. leaves ethanolic extract in Wistar rats [Toxicidad oral aguda y por dosis repetidas durante 28 días del extracto etanólico de hojas de Ruta angustifolia Pers. en ratas Wistar] Tutik … Continue reading Toxicity evaluation of Ruta angustifolia leaves ethanolic extract
Adolescents in Indonesia and COVID-19 pandemic
J. Pharm. Pharmacogn. Res., vol. 11, no. 3, pp. 426-436, May-June 2023. DOI: https://doi.org/10.56499/jppres22.1560_11.3.426 Original Article Perception, mental health, and social media exposure on adolescents in Indonesia during COVID-19 pandemic [Percepción, salud mental y exposición a los medios sociales en adolescentes de Indonesia durante la pandemia de COVID-19] Efa Nugroho1*, Alfiana Ainun Nisa1, Widya Hary Cahyati1, … Continue reading Adolescents in Indonesia and COVID-19 pandemic
Decaffeinated green tea and coffee extracts and metabolic syndrome
J. Pharm. Pharmacogn. Res., vol. 11, no. 3, pp. 414-425, May-June 2023. DOI: https://doi.org/10.56499/jppres23.1593_11.3.414 Original Article Decaffeinated green tea and green coffee extracts as metformin’s add-on enhance metabolic syndrome risk factors and improve the cardiac insulin-gene-related pathway [Extractos de té verde y café verde descafeinados como complemento de la metformina mejoran los factores de riesgo del … Continue reading Decaffeinated green tea and coffee extracts and metabolic syndrome

© 2013-2020 by the authors; licensee JPPRes, Antofagasta, Chile. This journal is an open-access journal distributed under the terms and conditions of the Creative Commons Attribution license-Non Commercial 4.0 international. The content on this site is intended for health professionals. If you are not a health professional, please talk to your doctor about any doubts or concerns regarding your health

Made with ♥ by AVAGAX Studio